Investigational Drug Paliperidone ER Significantly Delayed Symptom Recurrence In Clinical Study Of Patients With Schizophrenia
Mon, 17 Jul 2006 06:00 AM EST
... Paliperidone extended-release (ER) tablets, an investigational, once-daily oral medication, maintained long-term symptom stability in patients with schizophrenia. Data from a multinational, multicenter phase III study were presented today at the Biennial Congress of the Collegium Internationale Neuro-Psychopharmacologicum (CINP). [click link for full article] ...
Related Topics
- Schizophrenia
- Clinical Trials
- Divalproex
- Pharmacology
- Psychopharmacology
- Methylphenidate ER
- Valproic Acid Delayed or Extended-Release or Sprinkle Capsule
- Depression
- Thyroid Cancer
- Niacin Extended Release
- Clozapine
- Drug Abuse
- Prescription Drug Abuse
- Prescription Drugs Abuse
- Drug Safety
- Prescription Drugs
- Isosorbide Mononitrate
- Memantine
- Urinalysis
- Tarceva

Not Signed In -


